Combining Immune Checkpoint Inhibitors and Kinase-Inhibiting Supramolecular Therapeutics for Enhanced Anticancer Efficacy

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 29, 2016
Source ID
10.1021/acsnano.6b01600

Entities

People

  • Ashish Kulkarni
  • Prithvi Raj Pandey
  • Shiladitya Sengupta
  • Siva Kumar Natarajan
  • Vineethkrishna Chandrasekar

Organizations

  • American Cancer Society
  • American Lung Association
  • Brigham and Women's Hospital
  • Congressionally Directed Medical Research Programs
  • Dana–Farber Cancer Institute
  • Harvard Medical School
  • Harvard–MIT Division of Health Sciences and Technology
  • Indo-US Science and Technology Forum
  • National Cancer Institute
  • United States Department of Defense